Fiboscan®

FibroScan is the world’s first non-invasive device capable of instant quantification of liver fibrosis. It uses a patented technology known as Vibration-Controlled Transient Elastography (VCTE) to provide reliable, accurate and reproducible assessment of liver tissue stiffness.

FibroScan® is a safe and comparable alternative to liver biopsy. Therefore, it can be used in patients with chronic liver diseases as well as in those without underlying liver disease.

• Chronic hepatitis B and Hepatitis C carrier
• Persons infected by HIV
• Persons with high blood pressure or high cholestorol
• Persons with fatty liver disease
• Diabetes patients
• Persons with high alcohol intake

The traditional examination is liver biopsy (liver biopsy). However, this examination is more invasive and risky, may require local anesthesia and hospital observation. FibroScan is non-invasive and safe,and can be used repeatedly to monitor patients with chronic liver disease. Another traditional method is ultrasound, which is not harmful to body, but can only diagnose the initial stage of liver cirrhosis and cannot determine the predecessor of liver cirrhosis: liver fibrosis.

The scan will only take a few minutes, with you lying down. Several measurements will be obtained by the probe placed on your right abdomen. The technician will follow strict guidelines to only obtain measurements from a valid segment of your liver.